Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP140171171 | Pfizer: COVID pill cut hospital, death risk by 90%
CP143124202 | FDA panel narrowly backs COVID-19 pill from Merck
CP135613306 | WH: Merck pill 'good news,' vaccine still key
CP128043122 | Alberta's COVID-19 plan could have ripple effects: top doctors
CP111103621 | Dr. Theresa Tam says Canadians need to cut their contacts by a quarter to slow COVID-19 spread
CP140935871 | Health Canada says decision on whether to OK kids’ COVID-19 vaccine expected ‘in one-to-two weeks.’
Merck: Experimental pill cuts worst COVID effects
Drugmaker Merck says it will soon ask U.S. health officials to authorize use of an experimental COVID-19 pill that Merck says reduces hospitalizations and deaths by half. A Food and Drug Administration decision could come within weeks after that. (Oct. 1)
Actions
Add to collection
Add to cart
Information
Source name:
The Associated Press
Unique identifier:
CP135613271
Legacy Identifier:
5c5a58521ddc41579d8ac97dde477ee6
Type:
Video
Duration:
1m34s
Dimensions:
1920px × 1080px 115.02 MB
Usage rights:
Digital platform use only. Broadcast rights and editing of content prohibited.
Create Date:
10/1/2021 1:32:30 PM
Display aspect ratio:
16:9